[{"address1": "1500 Broadway", "address2": "Suite 1401", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "332 208 6102", "website": "https://www.nuvationbio.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-868, a BD2 selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation, including oncogenes comprising c-myc; NUV-1156, an AR binder Xtandi that address advanced stage prostate cancers with the potential to move into earlier lines typically treated with surgical prostatectomy; and drug-drug conjugate (DDC) platform which leverages a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies to deliver anti-cancer therapeutics to cancer cells, as well as NUV-1176, a PARP inhibitor to address ER+ breast and ovarian cancer. The company was founded in 2018 and is headquartered in New York, New York.", "fullTimeEmployees": 51, "companyOfficers": [{"maxAge": 1, "name": "Dr. David T. Hung M.D.", "age": 65, "title": "Founder, President, CEO & Director", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": 944509, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David C. Hanley Ph.D.", "age": 53, "title": "Chief Technical Operations Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 586040, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Moses  Makunje", "age": 44, "title": "Principal Accounting Officer & Principal Financial Officer", "yearBorn": 1979, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary  Hattersley Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 687881, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy  Markel", "age": 58, "title": "Chief People Officer", "yearBorn": 1965, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kerry A. Wentworth", "age": 50, "title": "Chief Regulatory Officer", "yearBorn": 1973, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Liu M.D., Ph.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Colleen  Sjogren", "title": "Chief Commercial Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1711929600, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.15, "open": 3.11, "dayLow": 2.87, "dayHigh": 3.2, "regularMarketPreviousClose": 3.15, "regularMarketOpen": 3.11, "regularMarketDayLow": 2.87, "regularMarketDayHigh": 3.2, "beta": 1.373, "forwardPE": -5.5, "volume": 1051255, "regularMarketVolume": 1051255, "averageVolume": 1271406, "averageVolume10days": 1503300, "averageDailyVolume10Day": 1503300, "bid": 2.91, "ask": 2.92, "bidSize": 3000, "askSize": 3000, "marketCap": 732675264, "fiftyTwoWeekLow": 0.95, "fiftyTwoWeekHigh": 4.16, "fiftyDayAverage": 2.3428, "twoHundredDayAverage": 1.70827, "currency": "USD", "enterpriseValue": 43361272, "floatShares": 124847583, "sharesOutstanding": 245692000, "sharesShort": 3006181, "sharesShortPriorMonth": 2647347, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0137, "heldPercentInsiders": 0.23967, "heldPercentInstitutions": 0.55008, "shortRatio": 1.44, "shortPercentOfFloat": 0.0253, "bookValue": 2.763, "priceToBook": 1.0749186, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -75802000, "trailingEps": -0.35, "forwardEps": -0.54, "enterpriseToEbitda": -0.435, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "NUVB", "underlyingSymbol": "NUVB", "shortName": "Nuvation Bio Inc.", "longName": "Nuvation Bio Inc.", "firstTradeDateEpochUtc": 1598448600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "292fc361-56ab-3994-b08a-1a4c45c2f81b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.97, "targetHighPrice": 10.0, "targetLowPrice": 4.0, "targetMeanPrice": 5.7, "targetMedianPrice": 5.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 611212992, "totalCashPerShare": 2.79, "ebitda": -99600000, "totalDebt": 4007000, "quickRatio": 44.004, "currentRatio": 44.113, "debtToEquity": 0.662, "returnOnAssets": -0.09646, "returnOnEquity": -0.120299995, "freeCashflow": -41592752, "operatingCashflow": -67999000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-13"}]